Release Date: 23/11/20 12:32 Summary: Positive IHL-675A in vivo results and FDA Pathway Price Sensitive: Yes Download Document 439.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%